Frank H. Laukien net worth and biography

Frank Laukien Biography and Net Worth

CEO of Bruker

Dr. Frank H. Laukien has been our Chairman, President and Chief Executive Officer since February 1991 and is our largest stockholder. Dr. Laukien also serves as a director of various subsidiaries of Bruker, none of which are publicly traded companies. Dr. Laukien served as a director of ALDA for several terms in the past, including as its Chairman from 2002 to 2003. Dr. Laukien holds a Bachelor of Science degree in physics from MIT, as well as a Ph.D. in chemical physics from Harvard. Dr. Laukien was a member of the Dean’s Advisory Committee of the MIT School of Science until 2014, and a Trustee of the Rivers School in Weston, Massachusetts until 2013. In May 2017, Dr. Laukien was elected a senator of acatech, the German National Academy of Science and Engineering. For 2021, Dr. Laukien has been appointed as a Visiting Scholar (part-time, unpaid) at the Department of Chemistry & Chemical Biology at Harvard University. As our largest stockholder and based on his long history of leading profitable growth at Bruker, Dr. Laukien brings to the Board the perspective of a significant stakeholder with an in-depth knowledge of all aspects of our operations. He also provides extensive executive experience in organizational management, strategic planning, finance, global business development and life science tools markets, as well as the scientific and technical background required for a deep understanding of our key technologies, markets and industry dynamics.

What is Frank H. Laukien's net worth?: The estimated net worth of Frank H. Laukien is at least $1.66 billion as of November 18th, 2024. Dr. Laukien owns 38,439,563 shares of Bruker stock worth more than $1,662,126,704 as of March 26th. This net worth evaluation does not reflect any other assets that Dr. Laukien may own. Additionally, Dr. Laukien receives an annual salary of $2,530,000.00 as CEO at Bruker. Learn More about Frank H. Laukien's net worth.
How old is Frank H. Laukien?: Dr. Laukien is currently 64 years old. There are 6 older executives and no younger executives at Bruker. Learn More on Frank H. Laukien's age.
What is Frank H. Laukien's salary?: As the CEO of Bruker Co., Dr. Laukien earns $2,530,000.00 per year. Learn More on Frank H. Laukien's salary.
How do I contact Frank H. Laukien?: The corporate mailing address for Dr. Laukien and other Bruker executives is 40 Manning Road, Billerica MA, 01821. Bruker can also be reached via phone at (978) 663-3660 and via email at investor.relations@bruker.com. Learn More on Frank H. Laukien's contact information.
Has Frank H. Laukien been buying or selling shares of Bruker?: Frank H. Laukien has not been actively trading shares of Bruker during the past quarter. Most recently, on Monday, November 18th, Frank H. Laukien bought 100,000 shares of Bruker stock. The stock was acquired at an average cost of $50.14 per share, with a total value of $5,014,000.00. Following the completion of the transaction, the chief executive officer now directly owns 38,439,563 shares of the company's stock, valued at $1,927,359,688.82. Learn More on Frank H. Laukien's trading history.
Who are Bruker's active insiders?: Bruker's insider roster includes Thomas Bures (CAO), Cynthia Friend (Director), Gerald Herman (CFO), Marc Kastner (Director), Frank Laukien (CEO), Mark Munch (VP), Richard Packer (Director), and Hermann Requardt (Director). Learn More on Bruker's active insiders.
Are insiders buying or selling shares of Bruker?: In the last year, Bruker insiders bought shares 2 times. They purchased a total of 100,500 shares worth more than $5,037,700.00. The most recent insider tranaction occured on March, 10th when CAO Thomas Bures bought 500 shares worth more than $23,700.00. Insiders at Bruker own 28.3% of the company. Learn More about insider trades at Bruker.
Information on this page was last updated on 3/10/2025.

Frank H. Laukien Insider Trading History at Bruker

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/18/2024	Buy	100,000	$50.14	$5,014,000.00	38,439,563
8/8/2023	Sell	37,947	$64.81	$2,459,345.07	38,217,344
5/8/2023	Sell	89,018	$77.05	$6,858,836.90	38,210,993
5/3/2023	Sell	16,435	$79.21	$1,301,816.35	38,352,034
5/1/2023	Sell	82,795	$78.75	$6,520,106.25	38,262,287
4/24/2023	Sell	148,230	$81.02	$12,009,594.60	38,349,926
8/16/2021	Sell	71,594	$83.83	$6,001,725.02
6/3/2019	Sell	400,000	$41.48	$16,592,000.00	37,991,030
5/30/2019	Sell	400,000	$41.48	$16,592,000.00	37,991,030
8/10/2017	Buy	2,335	$27.39	$63,955.65	37,791,386
5/19/2017	Buy	3,200	$26.13	$83,616.00	37,789,051
5/18/2017	Buy	73,000	$26.22	$1,914,060.00	37,750,851
5/16/2017	Buy	1,920	$25.88	$49,689.60	37,712,851
3/17/2017	Buy	4,300	$23.34	$100,362.00	37,710,931
3/13/2017	Buy	2,300	$23.74	$54,602.00	37,706,631
12/15/2016	Buy	4,725	$21.22	$100,264.50	37,704,331
11/25/2016	Buy	2,124	$22.90	$48,639.60	37,699,606
8/5/2016	Buy	4,500	$22.17	$99,765.00	37,658,733
6/14/2016	Buy	4,174	$23.95	$99,967.30	37,654,233
6/15/2015	Buy	1,000,000	$19.50	$19,500,000.00
6/11/2015	Buy	5,901	$20.31	$119,849.31
2/25/2015	Buy	5,271	$18.95	$99,885.45
12/14/2012	Buy	50,000	$14.68	$734,000.00

See Full Table

Frank H. Laukien Buying and Selling Activity at Bruker

Bruker Company Overview

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.

Today's Range

Now: $43.24

$42.70

$44.87

50 Day Range

MA: $51.43

$43.24

$60.12

2 Week Range

Now: $43.24

$42.70

$94.52

Volume

1,963,889 shs

Average Volume

1,316,586 shs

Market Capitalization

$6.56 billion

P/E Ratio

56.90

Dividend Yield

0.45%

Beta

1.18

Frank Laukien Biography and Net Worth

What is Frank H. Laukien's net worth?

How old is Frank H. Laukien?

What is Frank H. Laukien's salary?

How do I contact Frank H. Laukien?

Has Frank H. Laukien been buying or selling shares of Bruker?

Who are Bruker's active insiders?

Are insiders buying or selling shares of Bruker?